Keyphrases
Kidney Transplant Recipients
100%
Kidney Transplantation
93%
Hemodialysis Patients
51%
Graft Survival
47%
Hemodialysis
37%
Confidence Interval
36%
Acute Kidney Injury
34%
Systematic Meta-analysis
34%
Graft Loss
32%
Chronic Kidney Disease
31%
Transplantation
26%
Humoral Response
25%
Obesity
24%
Retrospective Cohort Study
24%
SIADH
24%
Meta-analysis
23%
Kidney Transplant
23%
BNT162b2 Vaccine
23%
Immunosuppression
23%
DNA Repair
22%
Glomerular Hyperfiltration
22%
Multivariate Analysis
22%
Dialysis Patients
22%
Single Center
21%
Cardiovascular Morbidity
19%
Estimated Glomerular Filtration Rate
19%
Dialysis
18%
Peripheral Blood Mononuclear Cells
18%
Immunosuppression Reduction
18%
Randomized Controlled Trial
18%
Hazard Ratio
17%
Cardiovascular Mortality
17%
Anemia of Chronic Kidney Disease
17%
COVID-19
16%
Odds Ratio
16%
Third Dose
16%
Bacterial Infection
15%
Pretransplant
15%
Antibody Response
15%
Hemoglobin
15%
Patient Survival
15%
First Year
15%
Intravenous Iron
14%
Vaccine Dose
14%
BNT162b2
14%
Increased Mortality
14%
Chronic Kidney Disease Patients
14%
All-cause Mortality
13%
Etiology
13%
Antibody Level
13%
Medicine and Dentistry
Kidney Graft
87%
Kidney Transplantation
77%
Hemodialysis
50%
Chronic Kidney Disease
45%
Transplantation
40%
Acute Kidney Injury
34%
Graft Failure
30%
Immunosuppressive Treatment
29%
Infection
28%
Kidney Function
26%
Glomerular Filtration Rate
25%
Retrospective Cohort Study
25%
Cardiovascular System
24%
Randomized Controlled Trial
23%
Supplementation
23%
Ultrafiltration
23%
Systematic Review
22%
Meta-Analysis
22%
Graft Survival
22%
Retrospective Study
22%
Anemia
21%
DNA Repair
17%
Multivariate Analysis
16%
Bacterial Infection
15%
Cardiovascular Disease
14%
Hazard Ratio
14%
Diabetes
14%
Cancer
12%
Peripheral Blood Mononuclear Cell
12%
Syndrome of Inappropriate Antidiuretic Hormone Secretion
12%
Humoral Immunity
11%
COVID-19 Vaccine
11%
Percutaneous Aortic Valve Replacement
11%
Odds Ratio
10%
Retransplantation
9%
Calcineurin Inhibitor
9%
Symptom
9%
Antibody Response
9%
All Cause Mortality
8%
Univariate Analysis
8%
Immunosuppressive Drug
8%
Prevalence
8%
Adverse Event
8%
Proportional Hazards Model
8%
Drug Therapy
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
End Stage Renal Disease
8%
Cohort Analysis
7%
Nephropathy
7%
Bloodstream Infection
7%